Business Context and Reporting Period
Company: Healthcare Trust, Inc. (Note: Input metadata referenced "National Healthcare Properties, Inc.", but the filing text identifies the registrant as Healthcare Trust, Inc.)
Filing Type: Form 8-K (Current Report)
Date: September 15, 2020
Context: The Company entered into a Preferred Stock Purchase Agreement (an "Equity Line") with B. Riley Principal Capital, LLC to secure a source of capital. This filing details the agreement terms, a related Registration Rights Agreement, and amendments to the Operating Partnership Agreement and Articles of Incorporation.
Key Financial Metrics and Capital Structure
This filing does not report operational financial metrics such as revenue, profit, cash flow, or margins. It focuses on capital structure and financing capacity:
- Maximum Commitment Amount: Up to $15 million in 7.375% Series A Cumulative Redeemable Perpetual Preferred Stock.
- Security Type: Preferred Shares with a $0.01 par value.
- Authorized Increase: 600,000 additional shares of Preferred Stock authorized via Articles Supplementary.
- Intended Use of Proceeds: Primarily to prepay amounts outstanding under the Company's credit facility as required; remaining proceeds for general corporate and working capital purposes.
Material Changes and Transaction Terms
The primary material change is the establishment of the Equity Line with the following specific terms:
- Purchase Price: The lesser of (a) 97.5% of the closing price of the Preferred Shares (subject to IRS "Fastpay Maximum" rules) or (b) 98.25% of the Fastpay Maximum.
- Volume Limits: Up to 3,500 Preferred Shares per purchase notice, with a potential mutual agreement to increase this to 7,500 shares per purchase.
- Frequency: Purchase notices must be delivered at least four trading days apart (except for the first notice after the initial purchase).
- Ownership Cap: The Investor cannot be required to purchase shares if it would cause them to beneficially own more than 9.99% of the issued and outstanding Preferred Shares.
- Termination: The agreement terminates automatically on the earliest of: expiration of the Form S-11, December 31, 2023, or the date the Maximum Commitment Amount is purchased. The Company may terminate at any time without penalty.
Outlook, Risks, and Contingencies
Conditions Precedent: Sales under the agreement may only commence after a registration statement on Form S-11 is declared effective by the SEC. If the Commencement Date has not occurred by December 31, 2020, a non-breaching party may terminate the agreement.
Risk Factors: The filing includes standard forward-looking statement disclaimers. Specific risks cited include:
- Adverse effects of the ongoing global coronavirus pandemic on the Company, its tenants, operators, and the global economy.
- Uncertainty regarding future rent collections based on second-quarter data.
- General market risks and uncertainties outside the Company's control.
Investor Verification Checklist
- Verify the effectiveness of the Form S-11 registration statement, which is a condition precedent to any sales under the Equity Line.
- Confirm the current status of the Company's credit facility to understand the immediate need for proceeds to prepay outstanding amounts.
- Monitor the "Fastpay Maximum" price limits to understand the potential discount at which shares may be sold.
- Review the 9.99% beneficial ownership limitation to assess the maximum potential volume of shares the Investor can be forced to purchase.
- Check for any updates on rent collection trends and pandemic-related impacts referenced in the risk factors.